Pacific Edge

Listed cancer diagnostics firm, Pacific Edge, wants to raise more than 21-million dollars to fund its next stage of development and market growth as the company says it's on the cusp of braking even. Audio

The cancer diagnostics firm, Pacific Edge, has reported a wider half-year loss as it closed an employee incentive scheme and invested for growth in the United States. Audio

Shares in the cancer diagnostics firm, Pacific Edge, have fallen 8 percent after the company reported a bigger annual loss and sought an additional 35 million dollars from investors. Audio

Pacific Edge will pay some investors half a million dollars in compensation as part of an agreement with the capital markets regulator over potential breaches of continuous disclosure rules. Audio

Pacific Edge has released another product which winnows out patients who present with blood in their urine, but who probably don't have bladder cancer. Audio

Pacific Edge says the company is gaining momentum and increasing its sales in key markets. Audio

Pacific Edge's first half loss of 4.7 million dollars is in line with market expectations. Audio